Most Popular White Papers
Bellwether Report.com is Scouting AVI Biopharma Inc.
M2 Presswire, August, 2006
 | Content provided in partnership with |  |
M2 PRESSWIRE-9 August 2006-bellwetherreport.com: Bellwether Report.com is Scouting AVI Biopharma Inc(C)1994-2006 M2 COMMUNICATIONS LTD RDATE:09082006 The Bellwether Report Takes Notice of AVI Biopharma Inc. (Nasdaq:AVII) AVI BioPharma (formerly Antivirals) develops therapeutic and gene-targeted treatments for cancer and heart disease.
Its lead products, NeuGene antisense drugs, block the function of certain genetic sequences to treat bone cancer and restenosis, a cardiovascular disease, as well as kidney and viral diseases. Biotech firm SuperGen bought the marketing rights ...
Read the rest of this article with a Free Trial at HighBeam Research.Find Research Guides for:
Find Featured Titles for: Reference
- Academe
- African American Review
- African Arts
- African Studies Review
- Afro-Americans in New York Life and History
- Alabama Heritage
- Alabama Review
- American Mathematical Monthly, The
- Anglican Theological Review
- Annals of Dyslexia
- Arab Studies Quarterly (ASQ)
- Auk, The
- Australian Journal of Anthropology, The
- Christian Century
- Natural History